FDA Approves , Generic ADHD Drugs.
The FDA has approved generic versions of Vyvanse for the first time, 'The Hill' reports. .
The new medications can treat ADHD
in people ages six and up.
They can also be used for "binge-eating
disorder in adults," 'The Hill' reports. .
Approval of the generic medications comes as the U.S. continues to experience a shortage of Adderall, which is commonly used to treat ADHD. .
The shortage was first announced
by the FDA in October 2022.
According to the CDC, ADHD prescriptions surged amid the pandemic as more
people turned to telehealth care. .
According to the CDC, ADHD prescriptions surged amid the pandemic as more
people turned to telehealth care. .
The unexpected demand, manufacturing issues
and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .
The unexpected demand, manufacturing issues
and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .
The unexpected demand, manufacturing issues
and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .
Since ADHD drugs are classified as
controlled substances, the FDA and DEA limit how much of the medicine can be produced each year.
But the increased demand and limited supply have prompted calls for the threshold to be raised.
Earlier this month, the FDA and DEA said
they are "working closely with numerous manufacturers, agencies and others in the supply chain to understand, prevent and reduce the impact of these shortages."